- Home
- HQL vs CLPT Comparison
HQL vs CLPT Comparison
Compare HQL & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQL | CLPT |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 689.4M | 467.9M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | HQL | CLPT |
|---|---|---|
| Price | $19.71 | $13.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 137.4K | ★ 490.6K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $25.75 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $13.88 | $8.27 |
| 52 Week High | $22.67 | $30.10 |
Technical Indicators
Market Signals| Indicator | HQL | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 36.84 |
| Support Level | $16.21 | $12.47 |
| Resistance Level | $21.32 | $13.59 |
| Average True Range (ATR) | 0.46 | 0.82 |
| MACD | -0.24 | -0.22 |
| Stochastic Oscillator | 3.89 | 2.68 |
Price Performance
Historical ComparisonAbout HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.